ERD

Repeated measures dose-finding design with time-trend detection in the presence of correlated toxicity data

Project: IDEAS

Updated at: 28-04-2024

Show more information

Project acronym IDEAS

Bayesian sequential integration within a preclinical PK-PD modeling framework: Lessons learned

Project: IDEAS

Updated at: 28-04-2024

Show more information

Project acronym IDEAS

Loss Functions in Restricted Parameter Spaces and Their Bayesian Applications

Project: IDEAS

Updated at: 28-04-2024

Show more information

Project acronym IDEAS

Interim analysis incorporating short- and long-term binary endpoints

Project: IDEAS

Updated at: 28-04-2024

Show more information

Project acronym IDEAS

e-learning course 1

Project: IDEAS

Updated at: 28-04-2024

Show more information

Project acronym IDEAS

Peer-reviewed publications

Project: IDEAS

Updated at: 28-04-2024

Show more information

Project acronym IDEAS

Release of summary videos

Project: IDEAS

Updated at: 28-04-2024

Show more information

Project acronym IDEAS

Dissemination workshop

Project: IDEAS

Updated at: 28-04-2024

Show more information

Project acronym IDEAS

A robust Bayesian meta-analytic approach to incorporate animal data into phase I oncology trials

Project: IDEAS

Updated at: 28-04-2024

Show more information

Project acronym IDEAS

Comparison of different approaches for dose response analysis

Project: IDEAS

Updated at: 28-04-2024

Show more information

Project acronym IDEAS

Pharmacological Treatment of Arterial Hypertension in Children and Adolescents

Project: IDEAS

Updated at: 28-04-2024

Show more information

Project acronym IDEAS

Dose-Finding Methods: Moving Away from the 3 + 3 to Include Richer Outcomes

Project: IDEAS

Updated at: 28-04-2024

Show more information

Project acronym IDEAS

The Assessment of Quality Attributes for Biosimilars: a Statistical Perspective on Current Practice and a Proposal

Project: IDEAS

Updated at: 28-04-2024

Show more information

Project acronym IDEAS

A Bayesian K-PD model for synergy: A case study

Project: IDEAS

Updated at: 28-04-2024

Show more information

Project acronym IDEAS

A novel measure of drug benefit–risk assessment based on Scale Loss Score

Project: IDEAS

Updated at: 28-04-2024

Show more information

Project acronym IDEAS

Properties of the weighted log-rank test in the design of confirmatory studies with delayed effects

Project: IDEAS

Updated at: 28-04-2024

Show more information

Project acronym IDEAS

Subgroup identification in clinical trials via the predicted individual treatment effect

Project: IDEAS

Updated at: 28-04-2024

Show more information

Project acronym IDEAS

Randomized dose-escalation designs for drug combination cancer trials with immunotherapy

Project: IDEAS

Updated at: 28-04-2024

Show more information

Project acronym IDEAS

Cancer phase I trial design using drug combinations when a fraction of dose limiting toxicities is attributable to one o...

Project: IDEAS

Updated at: 28-04-2024

Show more information

Project acronym IDEAS

Bayesian knowledge integration for an in vitro-in vivo correlation model

Project: IDEAS

Updated at: 28-04-2024

Show more information

Project acronym IDEAS

Comparing Approaches to Treatment Effect Estimation for Subgroups in Clinical Trials

Project: IDEAS

Updated at: 28-04-2024

Show more information

Project acronym IDEAS

An update on the clinical evidence that supports biosimilar approvals in Europe

Project: IDEAS

Updated at: 28-04-2024

Show more information

Project acronym IDEAS

An information theoretic phase I-II design for molecularly targeted agents that does not require an assumption of monoto...

Project: IDEAS

Updated at: 28-04-2024

Show more information

Project acronym IDEAS

A Bayesian model to estimate the cutoff and the clinical utility of a biomarker assay

Project: IDEAS

Updated at: 28-04-2024

Show more information

Project acronym IDEAS

Quantifying the association between progression-free survival and overall survival in oncology trials using Kendall's τ

Project: IDEAS

Updated at: 28-04-2024

Show more information

Project acronym IDEAS

Generalization of Cramér-Rao and Bhattacharyya inequalities for the weighted covariance matrix

Project: IDEAS

Updated at: 28-04-2024

Show more information

Project acronym IDEAS

A benchmark for dose finding studies with continuous outcomes

Project: IDEAS

Updated at: 28-04-2024

Show more information

Project acronym IDEAS

Review papers submitted

Project: IDEAS

Updated at: 28-04-2024

Show more information

Project acronym IDEAS

e-learning course 2

Project: IDEAS

Updated at: 28-04-2024

Show more information

Project acronym IDEAS

Final report

Project: IDEAS

Updated at: 28-04-2024

Show more information

Project acronym IDEAS

Resources

Selected filters:

Repeated measures dose-finding design with time-trend detection in the presence of correlated toxicity data

Bayesian sequential integration within a preclinical PK-PD modeling framework: Lessons learned

Loss Functions in Restricted Parameter Spaces and Their Bayesian Applications

Interim analysis incorporating short- and long-term binary endpoints

e-learning course 1

Peer-reviewed publications

Release of summary videos

Dissemination workshop

A robust Bayesian meta-analytic approach to incorporate animal data into phase I oncology trials

Comparison of different approaches for dose response analysis

Pharmacological Treatment of Arterial Hypertension in Children and Adolescents

Dose-Finding Methods: Moving Away from the 3 + 3 to Include Richer Outcomes

The Assessment of Quality Attributes for Biosimilars: a Statistical Perspective on Current Practice and a Proposal

A Bayesian K-PD model for synergy: A case study

A novel measure of drug benefit–risk assessment based on Scale Loss Score

Properties of the weighted log-rank test in the design of confirmatory studies with delayed effects

Subgroup identification in clinical trials via the predicted individual treatment effect

Randomized dose-escalation designs for drug combination cancer trials with immunotherapy

Cancer phase I trial design using drug combinations when a fraction of dose limiting toxicities is attributable to one o...

Bayesian knowledge integration for an in vitro-in vivo correlation model

Comparing Approaches to Treatment Effect Estimation for Subgroups in Clinical Trials

An update on the clinical evidence that supports biosimilar approvals in Europe

An information theoretic phase I-II design for molecularly targeted agents that does not require an assumption of monoto...

A Bayesian model to estimate the cutoff and the clinical utility of a biomarker assay

Quantifying the association between progression-free survival and overall survival in oncology trials using Kendall's τ

Generalization of Cramér-Rao and Bhattacharyya inequalities for the weighted covariance matrix

A benchmark for dose finding studies with continuous outcomes

Review papers submitted

e-learning course 2

Final report